Toll Free: 1-888-928-9744
Published: Mar, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Heat Biologics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Heat Biologics, Inc. - Product Pipeline Review - 2014', provides an overview of the Heat Biologics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Heat Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Heat Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Heat Biologics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Heat Biologics, Inc.'s pipeline products Reasons to buy - Evaluate Heat Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Heat Biologics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Heat Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Heat Biologics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Heat Biologics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Heat Biologics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Heat Biologics, Inc. Snapshot 5 Heat Biologics, Inc. Overview 5 Key Information 5 Key Facts 5 Heat Biologics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Heat Biologics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Heat Biologics, Inc. - Pipeline Products Glance 10 Heat Biologics, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 Heat Biologics, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Heat Biologics, Inc. - Drug Profiles 14 viagenpumatucel-L 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 HS-410 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 HS-210 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 HS-310 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 HS-510 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 HS-710 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Cell Therapy for Cancer 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Heat Biologics, Inc. - Pipeline Analysis 22 Heat Biologics, Inc. - Pipeline Products by Route of Administration 22 Heat Biologics, Inc. - Pipeline Products by Molecule Type 23 Heat Biologics, Inc. - Recent Pipeline Updates 24 Heat Biologics, Inc. - Dormant Projects 26 Heat Biologics, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables Heat Biologics, Inc., Key Information 5 Heat Biologics, Inc., Key Facts 5 Heat Biologics, Inc. - Pipeline by Indication, 2014 7 Heat Biologics, Inc. - Pipeline by Stage of Development, 2014 8 Heat Biologics, Inc. - Monotherapy Products in Pipeline, 2014 9 Heat Biologics, Inc. - Phase II, 2014 10 Heat Biologics, Inc. - Phase I, 2014 11 Heat Biologics, Inc. - Preclinical, 2014 12 Heat Biologics, Inc. - Discovery, 2014 13 Heat Biologics, Inc. - Pipeline by Route of Administration, 2014 22 Heat Biologics, Inc. - Pipeline by Molecule Type, 2014 23 Heat Biologics, Inc. - Recent Pipeline Updates, 2014 24 Heat Biologics, Inc. - Dormant Developmental Projects,2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.